Mega Lifesciences Public Company Limited Total Assets
Mega Lifesciences Public Company Limited total assets. Based on the latest financial reports, Mega Lifesciences Public Company Limited (MEGA) holds total assets worth ฿16.15 Billion THB (≈ $503.30 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Mega Lifesciences Public Company Limited (MEGA) total market value for the company's overall valuation and market capitalisation.
Total Assets of Mega Lifesciences Public Company Limited (2010–2025)
Total assets of Mega Lifesciences Public Company Limited from 2010 to 2025. This chart illustrates how Mega Lifesciences Public Company Limited's total assets have evolved over time, based on quarterly financial data. See latest Mega Lifesciences Public Company Limited stock price today for real-time trading data and today's change.
Mega Lifesciences Public Company Limited - Asset Composition Analysis
Mega Lifesciences Public Company Limited Total Assets Breakdown (December 2025)
Mega Lifesciences Public Company Limited total assets breakdown as of December 2025. Mega Lifesciences Public Company Limited's total assets of ฿16.15 Billion consist of 71.0% current assets and 29.0% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 26.8% |
| Accounts Receivable | ฿3.50 Billion | 21.9% |
| Inventory | ฿3.15 Billion | 19.7% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿867.17 Million | 5.4% |
| Goodwill | ฿428.51 Million | 2.7% |
Asset Composition Trend (2010–2025)
This chart illustrates how Mega Lifesciences Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Mega Lifesciences Public Company Limited's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mega Lifesciences Public Company Limited's current assets represent 71.0% of total assets in 2025, a decrease from 82.4% in 2010.
- Cash Position: Cash and equivalents constituted 26.8% of total assets in 2025, up from 4.5% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 21.9% of total assets.
Mega Lifesciences Public Company Limited Competitors by Total Assets
Key competitors of Mega Lifesciences Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥9.94 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321
|
China | CN¥3.63 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
|
China | CN¥7.35 Billion |
Mega Lifesciences Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.20 | 2.57 | 1.84 |
| Quick Ratio | 1.49 | 1.80 | 1.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿6.29 Billion | ฿6.18 Billion | ฿3.91 Billion |
Mega Lifesciences Public Company Limited - Advanced Valuation Insights
This section examines the relationship between Mega Lifesciences Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.03 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 12.6% |
| Total Assets | ฿16.00 Billion |
| Market Capitalization | $957.93 Million USD |
Valuation Analysis
Below Book Valuation: The market values Mega Lifesciences Public Company Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Mega Lifesciences Public Company Limited's assets grew by 12.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Mega Lifesciences Public Company Limited (2010–2025)
The table below shows the annual total assets of Mega Lifesciences Public Company Limited from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ฿16.00 Billion ≈ $498.60 Million |
+12.57% |
| 2024-12-31 | ฿14.21 Billion ≈ $442.92 Million |
-2.13% |
| 2023-12-31 | ฿14.52 Billion ≈ $452.56 Million |
-0.87% |
| 2022-12-31 | ฿14.65 Billion ≈ $456.52 Million |
+10.36% |
| 2021-12-31 | ฿13.27 Billion ≈ $413.67 Million |
+14.51% |
| 2020-12-31 | ฿11.59 Billion ≈ $361.24 Million |
+10.04% |
| 2019-12-31 | ฿10.53 Billion ≈ $328.30 Million |
+9.34% |
| 2018-12-31 | ฿9.63 Billion ≈ $300.24 Million |
+10.47% |
| 2017-12-31 | ฿8.72 Billion ≈ $271.79 Million |
+9.81% |
| 2016-12-31 | ฿7.94 Billion ≈ $247.51 Million |
+4.31% |
| 2015-12-31 | ฿7.61 Billion ≈ $237.28 Million |
+13.24% |
| 2014-12-31 | ฿6.72 Billion ≈ $209.53 Million |
+2.85% |
| 2013-12-31 | ฿6.54 Billion ≈ $203.72 Million |
+58.05% |
| 2012-12-31 | ฿4.14 Billion ≈ $128.89 Million |
+25.70% |
| 2011-12-31 | ฿3.29 Billion ≈ $102.54 Million |
+48.14% |
| 2010-12-31 | ฿2.22 Billion ≈ $69.22 Million |
-- |
About Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, includi… Read more